<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02891668</url>
  </required_header>
  <id_info>
    <org_study_id>Herlev-Hymaq</org_study_id>
    <nct_id>NCT02891668</nct_id>
  </id_info>
  <brief_title>Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition</brief_title>
  <acronym>HYMAQ</acronym>
  <official_title>Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herlev Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herlev Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project has the following primary aims:&#xD;
&#xD;
      The main objective is to delineate the association between changes in Resting energy&#xD;
      expenditure (REE) and QOL in hypothyroid patients before and after one year of L-T4&#xD;
      treatment. To achieve this, the investigators plan to compare newly diagnosed hypothyroid&#xD;
      patients soon after diagnosis before L-T4 therapy has been initiated after 6 months and after&#xD;
      1 year of treatment.&#xD;
&#xD;
      Primary endpoint is changes in REE compared to changes in QOL Secondary endpoint is changes&#xD;
      in cognitive function and changes in body composition before and after one year of treatment&#xD;
      and furthermore changes in insulin resistance following changes in body composition and free&#xD;
      fatty acids (FFA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects and Methods:&#xD;
&#xD;
      74 newly diagnosed hypothyroid patients of both genders and age between 20 and 75 years will&#xD;
      be recruited from the out-patients clinic in Herlev and Gentofte Hospital and the general&#xD;
      practitioners before start of substitution therapy. Participants will get an appointment&#xD;
      immediately after diagnosis to avoid unnecessary delay of treatment. Shortly after diagnosis&#xD;
      patients will undergo a test panel at the first experimental day, where patients arrives&#xD;
      fasting.&#xD;
&#xD;
        -  Psychological test using:&#xD;
&#xD;
             -  ThyPRO a thyroid-specific quality of life questionnaire(18),&#xD;
&#xD;
             -  Cognitive function by CALCAPÂ® Abbreviated Test Battery,&#xD;
&#xD;
             -  Perceived cognitive deficit questionnaire (Perceived Deficits Questionaire)&#xD;
&#xD;
             -  Major Depression Inventory (MDI) questionnaire&#xD;
&#xD;
        -  REE will be measured by a CCM-express calorimeter,&#xD;
&#xD;
        -  DEXA-scan&#xD;
&#xD;
        -  Blood samples will be taken and patients will be characterized through basic&#xD;
           information.&#xD;
&#xD;
        -  Insulin resistance will be assess through an oral glucose tolerance test (OGTT) At end&#xD;
           of the first experimental day patients will start L-T4 therapy following national&#xD;
           guidelines, with regular control of thyroid hormones to ensure optimal treatment. When&#xD;
           patients are euthyroid and TSH is below 4 * 10-3 International Units pr liter (mU/l)&#xD;
           patients will have blood samples monitored every 3 months for the rest of the trial.&#xD;
&#xD;
      After 6 and 12 months of treatment patients will undergo a similar experimental day and&#xD;
      return to their general practitioner or outpatient clinic.&#xD;
&#xD;
      A control group of 18 matched healthy persons will undergo the first experimental day in the&#xD;
      same way as the hypothyroid patients, except they do not start any kind of therapy and they&#xD;
      only participate in the first experimental day.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">May 20, 2018</completion_date>
  <primary_completion_date type="Actual">May 20, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in quality of life as measured with the ThyPro questionaire</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in resting energy expenditure in KCal/day</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Perceived Deficit Questionaire</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in insulin resistance evaluated by MATSUDA index</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in insulin resistance evaluated by HOMA index</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in cognitive tests</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in body composition asses through lean mass</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in body composition asses through visceral adipose tissue</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in body composition asses through fat mass</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in free fatty acids</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in cholesterol</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in serum triglycerides</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">42</enrollment>
  <condition>Hypothyroidism</condition>
  <arm_group>
    <arm_group_label>Hypothyroid</arm_group_label>
    <description>Levothyroxine treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <description>Matched on age and BMI 18 persons</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levothyroxine treatment</intervention_name>
    <description>Eltroxin/Euthyrox is part of the normal treatment for hypothyroidism, and the patient is treated equally, whether he/she participates or not.</description>
    <arm_group_label>Hypothyroid</arm_group_label>
    <other_name>Eltroxin, Euthyrox</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Hypothyroid patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  TSH &gt; 10 mU/liter&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Serious competing illness&#xD;
&#xD;
          -  Pregnancy or planning to become pregnant&#xD;
&#xD;
          -  Thyroidectomized patients&#xD;
&#xD;
          -  Unable to speak and understand danish&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bjarke Medici, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bjarke Medici</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of internal Medicine, Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <state>Region Hovedstaden</state>
        <zip>DK-2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>May 17, 2016</study_first_submitted>
  <study_first_submitted_qc>September 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>July 31, 2018</last_update_submitted>
  <last_update_submitted_qc>July 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Herlev Hospital</investigator_affiliation>
    <investigator_full_name>Bjarke Borregaard Medici</investigator_full_name>
    <investigator_title>MD, PH.d. student</investigator_title>
  </responsible_party>
  <keyword>Basal Metabolic rate</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Resting energy expenditure</keyword>
  <keyword>Insulin resistance</keyword>
  <keyword>Cognitive Function</keyword>
  <keyword>Body Composition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

